Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China
Lu, Shun, Yu, Yongfeng, Fu, Shijun, Ren, Hongye, Gangopadhyay, NupurVolume:
13
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0205827
Date:
October, 2018
File:
PDF, 1.22 MB
english, 2018